Peter von Dadelszen to Risk Factors
This is a "connection" page, showing publications Peter von Dadelszen has written about Risk Factors.
Connection Strength
0.108
-
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial. Pregnancy Hypertens. 2018 Jul; 13:121-126.
Score: 0.023
-
Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018 04; 71(4):659-665.
Score: 0.023
-
Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique. Pregnancy Hypertens. 2018 Jan; 11:26-31.
Score: 0.022
-
Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018 Jan; 11:115-123.
Score: 0.022
-
SARS-CoV-2 Infection in Pregnant Women and Their Newborns. Ann Glob Health. 2020 10 08; 86(1):132.
Score: 0.007
-
Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model. Crit Care. 2018 Oct 30; 22(1):278.
Score: 0.006
-
External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017 04; 69(4):705-711.
Score: 0.005